{"id":37074,"date":"2022-01-17T16:16:48","date_gmt":"2022-01-17T21:16:48","guid":{"rendered":"https:\/\/www.saratoga.com\/saratogabusinessjournal\/?p=37074"},"modified":"2022-01-17T16:16:48","modified_gmt":"2022-01-17T21:16:48","slug":"fingerpaint-continues-growth-acquires-a-company-in-london-and-in-north-carolina","status":"publish","type":"post","link":"https:\/\/www.saratoga.com\/saratogabusinessjournal\/2022\/01\/fingerpaint-continues-growth-acquires-a-company-in-london-and-in-north-carolina\/","title":{"rendered":"Fingerpaint Continues Growth, Acquires A Company In London, And In North Carolina"},"content":{"rendered":"
Fingerpaint, biopharma\u2019s global commercialization partner for analytics-enabled integrated solutions, has acquired two companies as it continues to expand.<\/p>\n
One company acquired is Engage, a London-based, award-winning, data and analytics\u2013enabled healthcare marketing firm.<\/p>\n
The MedThink, a North Carolina\u2013based company that empowers healthcare providers through medical communications.\u00a0<\/span><\/p>\n Engage will expand Fingerpaint\u2019s European footprint and complement the company\u2019s current data and analytics expertise. \u00a0<\/span><\/p>\n The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.<\/p>\n \u201cStrengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide,\u201d said Ed Mitzen, founder of Fingerpaint about Engage. \u201cOur combined global omnichannel marketing solutions guided by\u2014and rooted in\u2014data will further Fingerpaint\u2019s position as a transformative digital partner to biopharma\u2019s commercialization needs.\u201d\u00a0 \u00a0<\/span><\/p>\n Mary McGregor and Dave Chandler, both founders and managing partners of Engage, will continue to lead day-to-day operations.\u00a0 \u00a0<\/span><\/p>\n <\/span><\/span>\u201cIntegrating into Fingerpaint will allow us to leverage its award-winning creative and digital talent and maximize omnichannel campaigns as we continue to work with global brands at every stage of the commercialization process,\u201d said McGregor. \u00a0<\/span><\/p>\n \u201cCombining our expertise with Fingerpaint\u2019s will create best-in-class, performance-based digital capabilities for clients across the company\u2019s integrated firms,\u201d said Chandler. \u00a0<\/span><\/p>\n Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint. \u00a0<\/span><\/p>\n \u201cEngage will help expand the data and analytics capabilities the industry has come to expect from Fingerpaint, biopharma\u2019s leading commercialization partner,\u201d said Shamik Patel, partner at Knox Lane. \u00a0<\/span><\/p>\n Engage joins integrated Fingerpaint firms MedThink, a company that empowers healthcare providers through medical communications; Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.<\/p>\n Regarding MedThink, Mitzen said, \u201cAdding to our capabilities as our clients\u2019 needs evolve has always been a priority for Fingerpaint. Medical communications and education have never been more important than they are now given the ever-changing ways we reach healthcare stakeholders and the growing need to convey increasingly complex science behind many of today\u2019s therapies to ensure people have access to them.\u201d<\/p>\n Scott Goudy, president of MedThink, will continue to lead day-to-day operations.<\/p>\n \u201cJoining Fingerpaint will accelerate our mission of moving minds, moving markets, and moving medicine by leveraging the company\u2019s capabilities at every step of the commercialization process,\u201d said Goudy. \u201cWe are looking forward to creating new opportunities for our clients and our people.\u201d<\/p>\n \u201cThis acquisition will expand the company\u2019s service offerings and talent into an area we know is critical to the industry and will solidify Fingerpaint\u2019s position as biopharma\u2019s leading commercialization partner,\u201d said Patel of Knox Lane.<\/p>\n Engage and MedThink join integrated Fingerpaint firms Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.<\/p>\n Engage is a London-based, award-winning, data and analytics\u2013enabled healthcare marketing firm. It delivers global omnichannel marketing solutions powered by advanced data insights to deliver customer engagement strategies, content and tech development, campaign deployment, and real-time performance analysis.<\/p>\n MedThink empowers healthcare providers through medical communications built on a foundation of science, strategy, and innovation. It has two distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.<\/p>\n Fingerpaint is an award-winning global team of more than 700 people who are committed to creating and executing meaningful brand experiences for healthcare providers, care partners, and patients.<\/p>\n Fingerpaint was named 2021 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine\u2019s list of the 5,000 Fastest-Growing Companies for the past eight years.\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Fingerpaint, biopharma\u2019s global commercialization partner for analytics-enabled integrated solutions, has acquired two companies as it continues to expand. One company acquired is Engage, a London-based, award-winning, data and analytics\u2013enabled healthcare marketing firm. The MedThink, a North Carolina\u2013based company that empowers healthcare providers through medical communications.\u00a0 Engage will expand Fingerpaint\u2019s European footprint and complement the company\u2019s […]<\/p>\n","protected":false},"author":89,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-37074","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"\r\n